Pages that link to "Q30656350"
Jump to navigation
Jump to search
The following pages link to Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data (Q30656350):
Displaying 50 items.
- Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (Q22306384) (← links)
- Aldosterone antagonists for preventing the progression of chronic kidney disease (Q24194979) (← links)
- Angiotensin converting enzyme (ACE) gene polymorphism (ACEI/D) in hypertensive adults with ACE inhibitor-induced cough (Q24202036) (← links)
- Rheum officinale (a traditional Chinese medicine) for chronic kidney disease (Q24202076) (← links)
- Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease (Q24235834) (← links)
- Non-immunosuppressive treatment for IgA nephropathy (Q24235956) (← links)
- Aldosterone antagonists for preventing the progression of chronic kidney disease (Q24239909) (← links)
- Antihypertensive treatment for kidney transplant recipients (Q24240164) (← links)
- Rheum officinale (a Chinese medicinal herb) for chronic kidney disease (Q24241536) (← links)
- Aldosterone antagonists for preventing the progression of chronic kidney disease (Q24243615) (← links)
- Manidipine-delapril combination in the management of hypertension (Q24654799) (← links)
- Does the Angiotensin-converting enzyme (ACE) gene insertion/deletion polymorphism modify the response to ACE inhibitor therapy?--A systematic review (Q24816744) (← links)
- NGAL-Siderocalin in kidney disease (Q26863396) (← links)
- Antihypertensive treatment and renal protection: the role of drugs inhibiting the renin-angiotensin-aldosterone system (Q26865691) (← links)
- Treatment of chronic kidney disease (Q27694623) (← links)
- The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy (Q28211654) (← links)
- Combination therapy improves survival after acute myocardial infarction in the elderly with chronic kidney disease (Q28211805) (← links)
- Statins and Renin Angiotensin System Inhibitors Dose-Dependently Protect Hypertensive Patients against Dialysis Risk (Q28554193) (← links)
- A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension (Q30245091) (← links)
- Social Determinants of Racial Disparities in CKD. (Q30250319) (← links)
- ESCAPE: From hypertension to renal failure. (Q30360706) (← links)
- The costs and benefits of automatic estimated glomerular filtration rate reporting (Q30437160) (← links)
- Renoprotection by ACE inhibitors after severe hemolytic uremic syndrome (Q33360292) (← links)
- Effect of diet, enalapril, or losartan in post-diarrheal hemolytic uremic syndrome nephropathy (Q33395128) (← links)
- High prevalence of chronic kidney disease in Iran: a large population-based study (Q33404464) (← links)
- Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysis. (Q33414957) (← links)
- Slowing the progression of chronic renal insufficiency (Q33576086) (← links)
- Validation of the Kidney Failure Risk Equation in Manitoba (Q33606357) (← links)
- Primary care physicians' familiarity, beliefs, and perceived barriers to practice guidelines in non-diabetic CKD: a survey study (Q33612080) (← links)
- Development and analyses of evaluation criteria for meta-analysis-relationship between renin-angiotensin system inhibitor and diabetes mellitus (Q33686761) (← links)
- Avosentan for overt diabetic nephropathy (Q33702404) (← links)
- Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy (Q33748541) (← links)
- A simple algorithm to predict incident kidney disease (Q33771352) (← links)
- Prevalence, determinants, and management of chronic kidney disease in Karachi, Pakistan - a community based cross-sectional study (Q33785255) (← links)
- Early change in proteinuria as a surrogate end point for kidney disease progression: an individual patient meta-analysis (Q33805412) (← links)
- Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in patients with micro- and macroalbuminuria and other cardiovascular risk factors: a systematic review of randomized controlled trials (Q33836604) (← links)
- Toward a more collaborative federal response to chronic kidney disease (Q33871360) (← links)
- Slowing progression of chronic kidney disease (Q33873241) (← links)
- Renal failure (chronic) (Q33910618) (← links)
- Effects of lowering LDL cholesterol on progression of kidney disease (Q33974663) (← links)
- Treatment of hypertension with renin-angiotensin system inhibitors and renal dysfunction: a systematic review and meta-analysis. (Q34047349) (← links)
- Implementation of a CKD checklist for primary care providers (Q34124728) (← links)
- Prevalence of microalbuminuria and diagnostic value of dipstick proteinuria in outpatients from HIV clinics in Bukavu, the Democratic Republic of Congo (Q34184535) (← links)
- 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension (Q34274434) (← links)
- Population based screening for chronic kidney disease: cost effectiveness study (Q34286311) (← links)
- Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. (Q34299778) (← links)
- Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes (Q34331403) (← links)
- Association of the estimated 24-h urinary sodium excretion with albuminuria in adult koreans: the 2011 Korea National Health and Nutrition Examination Survey (Q34337479) (← links)
- A multi-marker approach to predict incident CKD and microalbuminuria (Q34457191) (← links)
- Screening for chronic kidney disease: preventing harm or harming the healthy? (Q34489522) (← links)